Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Dienogest Tablet 2 mg vs Visanne in healthy Thai female volunteers under fasting conditions
TCTR20250531002Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dienogest in endometriosis (2 arms), sponsored by Bio-innova. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
dienogest
03
Conditions
endometriosis
Beyond the preview
Go deeper on TCTR20250531002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250531002.